Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-24,000
Closed -$929K 2181
2015
Q4
$929K Sell
24,000
-48,700
-67% -$1.89M ﹤0.01% 1387
2015
Q3
$2.85M Buy
72,700
+57,300
+372% +$2.27M 0.01% 829
2015
Q2
$586K Buy
15,400
+100
+0.7% +$3.5K ﹤0.01% 1818
2015
Q1
$505K Buy
15,300
+6,900
+82% +$212K ﹤0.01% 1801
2014
Q4
$225K Sell
8,400
-7,700
-48% -$199K ﹤0.01% 2290
2014
Q3
$392K Sell
16,100
-17,300
-52% -$437K ﹤0.01% 2124
2014
Q2
$847K Buy
33,400
+1,100
+3% +$25.7K ﹤0.01% 1759
2014
Q1
$694K Buy
32,300
+15,700
+95% +$339K ﹤0.01% 1840
2013
Q4
$371K Sell
16,600
-13,700
-45% -$302K ﹤0.01% 2500
2013
Q3
$626K Sell
30,300
-10,600
-26% -$226K ﹤0.01% 2280
2013
Q2
$789K Buy
+40,900
New +$854K ﹤0.01% 2138

Other funds holding HOLX

Timber Hill's HOLX Position: Q2 2017 in Review

Timber Hill sold out of Hologic (HOLX) in Q2 2017, closing a stake of 21,354 shares — an estimated $909K sold.

Timber Hill first reported a position in HOLX in Q1 2014 and held it in 8 quarters. The position peaked at $1.93M in Q2 2014. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Timber Hill reported no remaining Hologic position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 21,354 Hologic shares in Q2 2017, an estimated $909K.
  • Timber Hill first reported a position in Hologic in Q1 2014 and held it in 8 quarters.
  • Timber Hill's Hologic position peaked at $1.93M in Q2 2014.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.